Convenor: Professor Carmel Hawley
Carmel Hawley will present an update on data and safety monitoring boards for clinical trials. She will discuss: documents providing guidance around these boards and how they are approaching new challenges; recommendations for the organisational structure; membership of DSMB, role of the chair, and conduct of meetings; responsibilities of the DSMB; conflicts of interest; sponsor responsibilities; finances for DSMB activities; handling liability; logistics of preparing for and conducting the meeting; principles of open and closed sessions; reaching a consensus and making recommendations; preparing the outline of a charter and dummy report; timetable for data cut, snapshot and distribution of data to DSMB members; presenting the data – format; role of unblinded statistician and interaction and responsiveness to DSMB members, particularly DSMB statistician; data presentation unmasked by treatment group? ; approaches to stopping rules for safety, efficacy or futility or logistics; what happens at the end of the study; dealing with tricky situations; modifying monitoring boards to make them fit for purpose.
Carmel Hawley MB BS (Hons) M.Med Sci (Medical Statistics) FRACP, is a physician researcher and Clinical Trialist. Her clinical expertise is in Nephrology and is currently Assistant Director for the Haemodialysis program at the Princess Alexandra Hospital, Brisbane, Queensland, Australia, Professor of Medicine UQ and the Inaugural Chair of the Executive Operations Secretariat for the Australasian Kidney Trials Network (AKTN), a collaborative research network that has to date enabled over 18 multi-centre investigator-initiated clinical trials, many in collaboration with international research partners. She has been involved in DSMB activities for 15 years for activities related to investigator-initiated trials. Professor Hawley is a Fellow of the Academy of Health and Medical Sciences, and a key member of several national and international collaborations. She has published over 400 peer-reviewed articles and has been the recipient of upwards of $47,800,000 in research grant funding, primarily from the National Health and Medical Research Council’s federal grant program. In recognition of her significant contribution to the field of nephrology research, in 2018 Professor Hawley was awarded Kidney Health Australia’s highest accolade, the Kincaid-Smith medal.
Latest Resources
-
-
STInG Chat – How to build a career as a clinical trials biostatistician
-
Webinar recording: APT Virtual Clinic – SEISMIC and IVCare
-
Webinar recording: APT Virtual Clinic – ED Asthma and CAPTIVATE
-
Webinar recording: Historical and non-concurrent controls in clinical trials
-
STInG Chat – ‘Securing Funding: Tips and Tricks for Investigator Grants’
-
Webinar recording: APT Virtual Clinic – ACT-GLOBAL Adaptive Platform Trial for Stroke
-
Webinar recording: APT Virtual Clinic – UNSW / Black Dog Institute on Treatment-Resistant Depression
-
Webinar recording: Introduction to Git for Clinical Statisticians
-
The processes involved in a Data and Safety Monitoring Board/Committee with special reference to the role of the various statisticians
-
ACTA STInG grant advice for trial statisticians
-
Webinar recording: APT Virtual Clinic – PLATIPUS: A Platform for Adaptive Trials in Perinatal Units
-
ACTA STInGChat – ‘Climbing the Career Cascade’
-
Webinar recording: APT Virtual Clinic – Schizophrenia Platform for Improving Recovery with Integrated Trials
-
Seamless Phase 2_3 Trials in Oncology
-
Adaptive Design Clinical Trials
-
Career paths for academic biostatisticians
-
Workshops and Virtual Clinics on Adaptive Platform Trials
-
Webinar recording: APT Virtual Clinic – the BAT and PASSPORT Trials
-
Exploring greater partnership between Clinical Trial Networks, Clinical Quality Registries and Trial Coordinating Centres with Industry
-
ACTA STInG: N-of-1 Trials Webinar Series – Webinar 2
-
ACTA STInG: N-of-1 Trials Webinar Series – Webinar 1
-
Effective strategies to manage data integrity risks webinar
-
The Data Lifecycle: Ethical use of data webinar
-
Transparency in data analyses webinar
-
Webinar PIONEERing estimands in Clinical Research
-
Estimands: Not just a statistical issue
-
Resource for trial statisticians planning to apply for an academic promotion
-
Guidance on Peer Reviewing the Statistical Aspects of a Medical Paper
-
Protocols and Statistical Analysis Plans (SAPs) for Adaptive and Platform Trials
-
Webinar: Estimands in Oncology – How and Why
-
Seven steps for statistical success in clinical trials [Good clinical practice guidelines] Part 2
-
Seven steps for statistical success in clinical trials [Good clinical practice guidelines] Part 1
-
Data and Safety Monitoring Boards Webinar Series: Statistical Principles
-
Data and Safety Monitoring Boards Webinar Series: How to plan well and be prepared for the unexpected
-
Joint webinar on estimands in clinical trials
Latest Events
-
ACTA Virtual Clinics on Adaptive Platform Trials 2024
-
Webinar: Introduction to Git for Clinical Statisticians
-
ACTA STInG Trials Webinar Series: Seamless Phase 2/3 Designs in Oncology
-
Platform trials and master protocols – Workshop
-
ACTA STInG – Stata and R Markdown Demonstrations
-
Improving clinical trial recruitment through innovative technologies
-
ACTA STInG 3 part webinar series on Data Transparency (DT)
-
Clinical Trials 2021: National Tribute and Award Ceremony
-
Clarifying clinical trial aims and analysis using the estimands framework
-
Practical approaches to Adaptive Trial Simulation
-
An Introduction to Adaptive Trial Designs
-
Seven steps for statistical success in clinical trials [Good clinical practice guidelines] Part 2
-
Seven steps for statistical success in clinical trials [Good clinical practice guidelines] Part 1
-
Statistical principles – Data and Safety Monitoring Boards Webinar Series
-
Webinar: Data Safety and Monitoring Boards for Adaptive Trials
-
Bayesian Adaptive Randomised Clinical Trials Workshop, Sydney
-
Bayesian Adaptive Randomised Clinical Trials Workshop, Melbourne
-
Bayesian Adaptive Trials Workshops: Perth
-
Workshop: Pragmatic randomised trial designs for evaluating health policy and practice change interventions